Sign inJoin waitlistJoin the waitlist

Julie Talano

Bone Marrow Transplant Program Director · Medical College of Wisconsin Affiliated Hospitals, Inc

Credentials: · ·

History

Bone Marrow Transplant · Medical College of Wisconsin Affiliated Hospitals, Inc
Present
Bone Marrow Transplant · Medical College of Wisconsin Affiliated Hospitals, Inc
Present
Blood and Marrow Transplant · Children's Wisconsin - Fox Valley
Present

Medical College of Wisconsin - Milwaukee
2002–2003
Pediatric Hematology Oncology
Medical College of Wisconsin Affiliated Hospitals, Inc
1999–2002
Ann & Robert H Lurie Children's Hospital of Chicago
1995–1998
Georgetown University, BS
Northwestern University Feinberg School of Medicine
1991–1995

Research

Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A…
Transplantation and Cellular Therapy · 2021 · 172 citations
Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis
Blood Advances · 2017 · Last of 7 authors · 103 citations
Association of Crohn's disease, thiopurines, and primary epstein-barr virus infection with hemophagocytic lymphohistiocytosis
The Journal of Pediatrics · 2011 · 63 citations

David Margolis
6 papers
Michael Pulsipher
5 papers
Mitchell Cairo
4 papers
Alfred Gillio
3 papers
Amy Moskop
3 papers · 2 as a fellow
JC
James Casper
3 papers
Michael Verneris
3 papers
Rachel Phelan
3 papers · 1 as a fellow
Sonali Chaudhury
3 papers
Susan Prockop
3 papers
AC
Alexandra Cheerva
2 papers
Alice Bertaina
2 papers

Clinical trials

CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL
Principal investigator · Terminated · Phase 1
Medical College of Wisconsin
2020–2025
Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device
Principal investigator · Active not recruiting · Phase 2
Julie-An M. Talano
2015–2026
Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV
Principal investigator · Completed · Phase 1
Medical College of Wisconsin
2012–2019
Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT
Sub-investigator · Recruiting · Phase 2
Medical College of Wisconsin
2021–2029